Literature DB >> 12140803

Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?

John R Teerlink1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140803     DOI: 10.1054/jcaf.2002.126486

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  10 in total

Review 1.  Endothelins: pathophysiology and treatment implications in chronic heart failure.

Authors:  John R Teerlink
Journal:  Curr Heart Fail Rep       Date:  2005-12

2.  Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.

Authors:  N F Kelland; D J Webb
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

Review 3.  The genetics of congestive heart failure.

Authors:  Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

4.  Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome. A prospective, multicenter study using conventional and Speckle tracking echocardiography.

Authors:  Mohamed Y Abd El Rahman; Axel Rentzsch; Philipp Scherber; Siegrun Mebus; Oliver Miera; Günther Balling; Petra Böttler; Karl-Otto Dubowy; Birgit Farahwaschy; Alfred Hager; Joachim Kreuder; Brigitte Peters; Felix Berger; Ingram Schulze-Neick; Hashim Abdul-Khaliq
Journal:  Clin Res Cardiol       Date:  2014-03-30       Impact factor: 5.460

Review 5.  Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.

Authors:  G Gromo; J Mann; J D Fitzgerald
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 6.  Beta-adrenergic stimulation and myocardial function in the failing heart.

Authors:  Ali El-Armouche; Thomas Eschenhagen
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

Review 7.  Pulmonary hypertension: types and treatments.

Authors:  Lisa J Rose-Jones; Vallerie V Mclaughlin
Journal:  Curr Cardiol Rev       Date:  2015

Review 8.  Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?

Authors:  Markus Hinder; B Alexander Yi; Thomas H Langenickel
Journal:  Clin Pharmacol Ther       Date:  2018-02-01       Impact factor: 6.875

Review 9.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

10.  Novel Pharmacologic Therapy of Heart Failure.

Authors:  Steven J. Hussein; John R. Teerlink
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.